Coronavirus channel feed

Bio­gen out­break now tied to 70 cas­es of coro­n­avirus as state to­tal more than dou­bles in 1 day

6 years ago

Coro­n­avirus up­date: Eli Lil­ly staffer tests pos­i­tive, FDA post­pones in­spec­tions and AACR is can­celed as out­break roils bio­phar­ma

6 years ago

Which top-lev­el Bio­gen ex­ec has test­ed pos­i­tive for coro­n­avirus? WSJ nar­rows the lot­tery to 4, in­clud­ing the CEO

6 years ago

Gates Foun­da­tion, Mas­ter­card, Well­come launch coro­n­avirus treat­ment ac­cel­er­a­tor as out­break deep­ens

6 years ago

Nine new coro­n­avirus cas­es are tied to the Bio­gen out­break — as in­fec­tions spread to 'close con­tact­s'

6 years ago
People
Pharma

ACC scraps its flag­ship event in Chica­go as Covid-19 fears spread faster than the virus

6 years ago

Bio­phar­ma stocks take a beat­ing as eco­nom­ic tur­moil takes its toll — but some play­ers with coro­n­avirus ef­forts un­der­way are up

6 years ago

As Bio­gen grap­ples with coro­n­avirus cri­sis, Big Phar­mas like Eli Lil­ly, Take­da hun­ker down, tell staffers to work from home

6 years ago
Pharma

Tal­ly of coro­n­avirus cas­es at Bio­gen spikes by 15 on Sun­day — and Cowen says one in­fect­ed ex­ec at­tend­ed big con­fer­ence

6 years ago

Bio­gen man­dates quar­an­tine, new work-from-home mea­sures for most staffers as coro­n­avirus trig­gers 5 more in­fec­tions

6 years ago

Lob­by­ing cam­paign killed pro­pos­al to set price lim­its on fu­ture coro­n­avirus drugs, vac­cines — re­port

6 years ago
R&D

Dana-Far­ber, MD An­der­son, MIT im­pose trav­el re­stric­tions amid broad­er ef­forts to con­tain coro­n­avirus dam­age in US

6 years ago

Three Bio­gen staffers test pos­i­tive for coro­n­avirus in wake of Boston ho­tel meet­ing

6 years ago

Fred Hutchin­son Cen­ter ini­ti­ates manda­to­ry work-from-home pol­i­cy as out­break roils busi­ness­es, con­fer­ences

6 years ago

Add Take­da and Al­ny­lam to the menu of glob­al drug­mak­ers look­ing to stymie the coro­n­avirus epi­dem­ic

6 years ago
R&D
Pharma

'Un­heard-of speed­s': Trump, new­ly warmed up to bio­phar­ma, prais­es in­dus­try's coro­n­avirus re­sponse at White House meet­ing

6 years ago

Ver­tex, Seat­tle Ge­net­ics, Alpine with­draw from in­vestor con­fer­ence as biotechs brace for coro­n­avirus

6 years ago
People

As US di­als up coro­n­avirus re­sponse, BIO taps Vir's George Scan­gos to head com­mit­tee co­or­di­nat­ing in­dus­try ef­forts

6 years ago
People

Why FDA can’t dis­close the first coro­n­avirus-re­lat­ed drug short­age

6 years ago
Pharma
FDA+

A 9/11-era Om­a­ha fa­cil­i­ty, an old Ebo­la drug, and the ubiq­ui­tous Dr. Fau­ci: In­side the first US nov­el coro­n­avirus tri­al

6 years ago
R&D
In Focus

Fol­low­ing US, Chi­na hos­pi­tal ef­forts, Gilead plots its own PhI­II tri­als for close­ly watched Covid-19 drug

6 years ago
R&D

FDA mon­i­tor­ing 20 drugs at risk of short­age due to coro­n­avirus

6 years ago
China
FDA+

First US Covid-19 tri­als set to get un­der­way in Ne­bras­ka and Wash­ing­ton, backed by NIH

6 years ago
R&D

Har­vard joins coro­n­avirus fight with $115M and a high-pro­file Chi­nese part­ner

6 years ago
Deals
China
First page Previous page 5758596061 Next page Last page
A service from the Financial Times